First-line chemotherapy for ovarian cancer - the controversy continues

被引：2
|
作者：
Kaye, SB [1 ]
机构：
[1] Royal Marsden Hosp, Inst Canc Res, Sutton, Surrey, England
来源：
BRITISH JOURNAL OF CANCER | 2002年 / 87卷 / 08期
关键词：
D O I：
10.1038/sj.bjc.6600568
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：813 / 814
页数：2
相关论文
共 50 条
  • [21] Irinotecan (CPT-11) and cisplatin as first-line chemotherapy for advanced ovarian cancer
    Sugiyama, T
    Yakushiji, M
    Kamura, T
    Ikeda, M
    Umesaki, N
    Hasegawa, K
    Ishikawa, M
    Saji, F
    Hiura, M
    Takahashi, T
    Sato, S
    Ochiai, K
    Kikkawa, F
    Takeuchi, S
    Ohashi, Y
    Noda, K
    ONCOLOGY, 2002, 63 (01) : 16 - 22
  • [22] First-line chemotherapy with carboplatin, cisplatin and cyclophosphamide (CCC) in advanced ovarian cancer (AOC)
    Edelmann, DZ
    Peretz, T
    Barak, V
    Anteby, SO
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 520 - 520
  • [23] Carboplatin plus paclitaxel as first-line chemotherapy in previously untreated advanced ovarian cancer
    duBois, A
    Luck, HJ
    Meier, W
    Mobus, V
    Costa, S
    Richter, B
    Bauknecht, T
    Warm, M
    Schroeder, W
    Olbricht, S
    Nitz, U
    Jackisch, C
    SEMINARS IN ONCOLOGY, 1997, 24 (04) : 28 - 33
  • [24] The Effect of Age on First-line Chemotherapy for Epithelial Ovarian Cancer and Primary Peritoneal Carcinoma
    Larbi, E.
    Madhuri, K.
    Essapen, S.
    Butler-Manuel, S.
    Tailor, A.
    Michael, A.
    CLINICAL ONCOLOGY, 2013, 25 (01) : 75 - 75
  • [25] First-line chemotherapy
    Kaye, S
    KEY ADVANCES IN THE CLINICAL MANAGEMENT OF OVARIAN CANCER, 2003, : 33 - 37
  • [26] First line chemotherapy of advanced ovarian cancer
    du Bois, A
    MEDIZINISCHE WELT, 2001, 52 (03): : 53 - +
  • [27] Brain structure and function in patients with ovarian cancer treated with first-line chemotherapy: a pilot study
    Correa, D. D.
    Root, J. C.
    Kryza-Lacombe, M.
    Mehta, M.
    Karimi, S.
    Hensley, M. L.
    Relkin, N.
    BRAIN IMAGING AND BEHAVIOR, 2017, 11 (06) : 1652 - 1663
  • [28] Usefulness of osteopontin (OPN) determinations in ovarian cancer patients who underwent first-line chemotherapy
    Mrochem-Kwarciak, Jolanta
    Mrochen-Domin, Izolda
    Wojcieszek, Andrzej
    Deja, Regina
    Chmura, Aleksandra
    Maslyk, Barbara
    Nowara, Elzbieta
    Kaleta, Beata
    Kolosza, Zofia
    Bartnik, Wieslawa
    GINEKOLOGIA POLSKA, 2011, 82 (12) : 911 - 917
  • [29] Genetic heterogeneity after first-line chemotherapy in high-grade serous ovarian cancer
    Lambrechts, Sandrina
    Smeets, Dominiek
    Moisse, Matthieu
    Braicu, Elena Ioana
    Vanderstichele, Adriaan
    Zhao, Hui
    Van Nieuwenhuysen, Els
    Berns, Els
    Sehouli, Jalid
    Zeillinger, Robert
    Darb-Esfahani, Silvia
    Castillo-Tong, Dan Cacsire
    Lambrechts, Diether
    Vergote, Ignace
    EUROPEAN JOURNAL OF CANCER, 2016, 53 : 51 - 64
  • [30] Characterization of neutropenic fever in patients receiving first-line adjuvant chemotherapy for epithelial ovarian cancer
    Sharma, Sameer
    Rezai, Katayoun
    Driscoll, Deborah
    Odunsi, Kunle
    Lele, Shashikant
    GYNECOLOGIC ONCOLOGY, 2006, 103 (01) : 181 - 185
12345